Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Pharma Industry Analysis

UpdatedMar 29, 2026
DataAggregated Company Financials
Companies5
  • 7D-3.5%
  • 3M-29.1%
  • 1Y-49.5%
  • YTD-29.6%

Over the last 7 days, the Pharma industry has dropped 3.5%, driven by Novo Nordisk declining 3.8%. The industry has fallen 50% in the last year. Earnings are forecast to grow by 4.5% annually.

Industry Valuation and Performance

Has the Danish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 29 Mar 2026DKK 1.1tDKK 340.0bDKK 106.8b12x10.3x3.2x
Tue, 24 Feb 2026DKK 1.2tDKK 340.0bDKK 106.8b12.1x11.3x3.5x
Thu, 22 Jan 2026DKK 1.8tDKK 345.8bDKK 108.6b16x16.1x5.1x
Sat, 20 Dec 2025DKK 1.5tDKK 345.8bDKK 108.6b13.3x13.5x4.2x
Mon, 17 Nov 2025DKK 1.5tDKK 345.8bDKK 108.6b13.3x13.6x4.3x
Wed, 15 Oct 2025DKK 1.7tDKK 341.3bDKK 115.5b14.4x14.7x5x
Fri, 12 Sep 2025DKK 1.6tDKK 341.3bDKK 115.5b13.8x14.1x4.8x
Sun, 10 Aug 2025DKK 1.5tDKK 340.6bDKK 115.2b12.9x13.1x4.4x
Tue, 08 Jul 2025DKK 2.0tDKK 331.8bDKK 108.8b18.7x18.7x6.1x
Thu, 05 Jun 2025DKK 2.2tDKK 331.8bDKK 108.8b20.2x20.2x6.6x
Sat, 03 May 2025DKK 2.1tDKK 317.9bDKK 104.9b20x19.9x6.6x
Mon, 31 Mar 2025DKK 2.2tDKK 317.9bDKK 104.9b20.8x20.7x6.8x
Wed, 26 Feb 2025DKK 3.0tDKK 317.9bDKK 104.9b28.9x28.5x9.4x
Fri, 24 Jan 2025DKK 2.7tDKK 297.4bDKK 98.2b27.2x27x8.9x
Sun, 22 Dec 2024DKK 2.7tDKK 297.4bDKK 98.2b27.5x27.3x9x
Tue, 19 Nov 2024DKK 3.2tDKK 297.4bDKK 98.2b33x32.7x10.8x
Thu, 17 Oct 2024DKK 3.6tDKK 283.9bDKK 93.2b39.6x39.1x12.8x
Sat, 14 Sep 2024DKK 4.2tDKK 283.9bDKK 93.2b45.3x44.6x14.6x
Mon, 12 Aug 2024DKK 4.1tDKK 283.1bDKK 92.9b45.3x44.7x14.7x
Wed, 10 Jul 2024DKK 4.4tDKK 269.3bDKK 92.2b48x47.3x16.2x
Fri, 07 Jun 2024DKK 4.4tDKK 269.3bDKK 92.2b48.4x47.5x16.3x
Sun, 05 May 2024DKK 3.8tDKK 269.1bDKK 92.1b42.3x41.7x14.3x
Tue, 02 Apr 2024DKK 4.0tDKK 257.0bDKK 86.4b47x46.2x15.5x
Thu, 29 Feb 2024DKK 3.8tDKK 257.0bDKK 86.4b44.5x43.8x14.7x
Sat, 27 Jan 2024DKK 3.3tDKK 238.8bDKK 78.2b43.3x42.5x13.9x
Mon, 25 Dec 2023DKK 3.2tDKK 238.8bDKK 78.2b41.1x40.3x13.2x
Wed, 22 Nov 2023DKK 3.2tDKK 238.8bDKK 78.2b41.5x40.7x13.3x
Fri, 20 Oct 2023DKK 3.1tDKK 225.4bDKK 70.1b45.5x44.4x13.8x
Sun, 17 Sep 2023DKK 3.0tDKK 225.4bDKK 70.1b44.3x43.3x13.5x
Tue, 15 Aug 2023DKK 2.8tDKK 224.8bDKK 69.9b41.2x40.4x12.6x
Thu, 13 Jul 2023DKK 2.4tDKK 211.8bDKK 63.8b37.9x37x11.2x
Sat, 10 Jun 2023DKK 2.5tDKK 211.8bDKK 63.8b40x39.2x11.8x
Mon, 08 May 2023DKK 2.5tDKK 211.1bDKK 63.4b40.2x39.6x11.9x
Wed, 05 Apr 2023DKK 2.5tDKK 199.7bDKK 57.8b43.9x43.2x12.5x
Price to Earnings Ratio

43.2x


Total Market Cap: DKK 2.5tTotal Earnings: DKK 57.8bTotal Revenue: DKK 199.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Pharma Industry Price to Earnings3Y Average 32x202420252026
Current Industry PE
  • Investors are pessimistic on the Danish Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 10.3x which is lower than its 3-year average PE of 32.0x.
  • The 3-year average PS ratio of 10.4x is higher than the industry's current PS ratio of 3.2x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 23% per year over the last three years.
  • Revenues for these companies have grown 19% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market-0.67%
Healthcare-2.60%
Pharma-3.48%
Pharma-3.48%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
HLUN B H. LundbeckDKK 38.663.1%
+DKK 1.2b		5.3%PE12x
STENO StenocareDKK 1.1622.1%
+DKK 9.0m		241.7%PS7.1x
PEG Pharma Equity GroupDKK 0.0895.5%
+DKK 5.6m		-36.2%PB4.3x

Latest News

NOVO B
DKK 228.50
Novo Nordisk
7D
-3.8%
1Y
-51.8%
PEG
DKK 0.089
Pharma Equity Group
7D
5.5%
1Y
-36.2%
ALK B
DKK 202.00
ALK-Abelló
7D
-1.9%
1Y
40.8%

ALK B: Future Upside Will Rely On Wider Anaphylaxis Spray Adoption

Analysts have kept their DKK price target for ALK-Abelló broadly unchanged at DKK 255, reflecting stable assumptions on fair value, discount rate, revenue growth, profit margin and future P/E. This signals a steady view on the company’s outlook.
HLUN B
DKK 38.66
H. Lundbeck
7D
3.1%
1Y
5.3%

HLUN B: Neurology Pipeline Progress Will Support Future Margin Expansion

Analysts have reduced their price target on H. Lundbeck to DKK 61.99 from DKK 66.52, reflecting updated assumptions for slightly softer revenue growth, profit margins, and a lower future P/E multiple.
STENO
DKK 1.16
Stenocare
7D
22.1%
1Y
241.7%